DS
XPH icon

DRW Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

DRW Securities’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-27,200
Closed -$1.2M – 255
2013
Q4 		$1.2M Buy
+27,200
New +$1.13M 0.05% 73

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
HF
Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

DRW Securities's XPH Position: Q1 2014 in Review

DRW Securities sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2014, closing a stake of 27,200 shares — an estimated $1.2M sold.

DRW Securities first reported a position in XPH in Q4 2013 and held it in 1 quarter. The position peaked at $1.2M in Q4 2013. 72 funds tracked by Wall St. Rank hold XPH as of Q1 2014.

  • DRW Securities reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2014 after selling out during the quarter.
  • DRW Securities sold 27,200 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2014, an estimated $1.2M.
  • DRW Securities first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2013 and held it in 1 quarter.
  • DRW Securities's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.2M in Q4 2013.
  • 72 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2014.

Based on DRW Securities's 13F filing for Q1 2014, filed 16 May 2014.